Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31901 - 31925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	PCDH7	5099	downregulated	Cisplatin results in decreased expression of PCDH7 mRNA	4p15.1	A22211
Cisplatin	Approved Investigational	PCNA	5111	upregulated	Cisplatin results in increased expression of PCNA mRNA	20p12.3	A22210 A22212
Cisplatin	Approved Investigational	PDE8A	5151	downregulated	Cisplatin results in decreased expression of PDE8A mRNA	15q25.3	A20427
Cisplatin	Approved Investigational	PDIA4	9601	downregulated	Cisplatin results in decreased expression of PDIA4 mRNA	7q36.1	A22210
Cisplatin	Approved Investigational	PDIA5	10954	upregulated	Cisplatin results in increased expression of PDIA5 mRNA	3q21.1	A20427
Cisplatin	Approved Investigational	PDK1	5163	downregulated	Cisplatin results in decreased expression of PDK1 mRNA	2q31.1	A22203 A20427
Cisplatin	Approved Investigational	PDK4	5166	upregulated	Cisplatin results in increased expression of PDK4 mRNA	7q21.3	A20427
Cisplatin	Approved Investigational	PDLIM1	9124	upregulated	Cisplatin results in increased expression of PDLIM1 mRNA	10q23.33	A20427
Cisplatin	Approved Investigational	PDPK1	5170	downregulated	Cisplatin results in decreased expression of PDPK1 mRNA	16p13.3	A22205
Cisplatin	Approved Investigational	PDSS2	57107	downregulated	Cisplatin results in decreased expression of PDSS2 mRNA	6q21	A22204
Cisplatin	Approved Investigational	PEAK1	79834	downregulated	Cisplatin results in decreased expression of PEAK1 mRNA	15q24.3	A22204
Cisplatin	Approved Investigational	PECR	55825	downregulated	Cisplatin results in decreased expression of PECR mRNA	2q35	A22203
Cisplatin	Approved Investigational	PELO	53918	downregulated	Cisplatin results in decreased expression of PELO mRNA	5q11.2	A21499
Cisplatin	Approved Investigational	PERP	64065	upregulated	Cisplatin results in increased expression of PERP mRNA	6q23.3	A22203
Cisplatin	Approved Investigational	PFKFB4	5210	downregulated	Cisplatin results in decreased expression of PFKFB4 mRNA	3p21.31	A20427
Cisplatin	Approved Investigational	PHLDA1	22822	downregulated	Cisplatin results in decreased expression of PHLDA1 mRNA	12q15	A22204
Cisplatin	Approved Investigational	PHLDA1	22822	upregulated	Cisplatin results in increased expression of PHLDA1 mRNA	12q15	A22211
Cisplatin	Approved Investigational	PHLDA3	23612	upregulated	Cisplatin results in increased expression of PHLDA3 mRNA	1q32.1	A22203 A20427
Cisplatin	Approved Investigational	PIDD1	55367	upregulated	Cisplatin results in increased expression of PIDD1 mRNA	11p15.5	A22212
Cisplatin	Approved Investigational	PIP5K1C	23396	downregulated	Cisplatin results in decreased expression of PIP5K1C mRNA	19p13.3	A20427
Cisplatin	Approved Investigational	PLEKHB2	55041	upregulated	Cisplatin results in increased expression of PLEKHB2 mRNA	2q21.1	A22203
Cisplatin	Approved Investigational	PLEKHF1	79156	downregulated	Cisplatin results in decreased expression of PLEKHF1 mRNA	19q12	A21499
Cisplatin	Approved Investigational	PLIN2	123	upregulated	Cisplatin results in increased expression of PLIN2 mRNA	9p22.1	A22203
Cisplatin	Approved Investigational	PLK2	10769	upregulated	Cisplatin results in increased expression of PLK2 mRNA	5q11.2	A22212 A21978
Cisplatin	Approved Investigational	PLK3	1263	upregulated	Cisplatin results in increased expression of PLK3 mRNA	1p34.1	A22204 A22212 A22203

Displaying entries 31901 - 31925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability